Clinical trial
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
NCT00441597 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00441597 |
|---|---|
| Title | Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo? |
| Official title | Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo? |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ischemia Reperfusion Injury, Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | atorvastatin |
| Enrollment | 30 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Mar 1, 2007 |
| Last update posted | Mar 17, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: